32L-23323-51067
5 vaccinations
10 coded responses
46 check-ins
10 free-text entries
4 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 945 / CA
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Pfizer-BioNTech
- 2021-01-13
- 2021-01-14
- 2021-01-15
-
2021-01-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-22
Health check-in — day 7, dose 1Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-27
-
2021-02-03
Dose 2 — Pfizer-BioNTech
-
2021-02-03
Health check-in — day 0, dose 2Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-10
Health check-in — day 7, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-02-17
-
2021-02-24
Survey response — day 21, dose 2MedDRA: Myalgia — Feeling: FairFree text: Muscle aches/pain increasing somewhat.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-03
Survey response — day 28, dose 2MedDRA: Bone pain, Fatigue, Myalgia — Feeling: FairFree text: Fatigue increase. Somewhat increased frequency of muscle & bone ache episodes.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-10
- 2021-03-17
-
2021-05-05
Survey response — 3 months, dose 2MedDRA: Fatigue, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Worsening fatigue, possibly due to preexisting heart condition.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-04
-
2021-11-18
Dose 3 — Pfizer-BioNTech
- 2022-02-06
-
2022-05-09
Dose 4 — Pfizer-BioNTech
-
2022-05-10
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Itching · Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2022-05-11
- 2022-05-12
- 2022-05-13
- 2022-05-14
- 2022-05-15
- 2022-05-16
-
2022-05-23
Survey response — day 14, dose 4MedDRA: Diarrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: DiahreaMedDRA releases: 2024-11 · check-in free text available
-
2022-05-30
Survey response — day 21, dose 4MedDRA: Haematological infection, Pre-existing disease, Skin infection — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Skin infections worse than past problem. Proceeded to blood - responding to IV antibiotics.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-30
Report sent to call center — day 21, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-06-01
-
2022-06-01
Call successfulNot applicable - Accidental Reporting
- 2022-06-06
-
2022-06-13
Survey response — day 35, dose 4MedDRA: Diarrhoea — Feeling: FairFree text: DiarrheaMedDRA releases: 2024-11 · check-in free text available
- 2022-06-20
-
2022-08-08
Survey response — 3 months, dose 4MedDRA: Sepsis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: SepsisMedDRA releases: 2024-11 · check-in free text available
-
2022-08-08
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-08-09
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-28
Dose 5 — Pfizer-BioNTech
- 2022-10-06
- 2022-10-12
- 2022-10-19
- 2022-10-26
-
2022-11-03
Survey response — day 35, dose 5MedDRA: Blister, Pain, Pain in extremity, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Overall torso/arms covered by painful blister-like lesions. No medical diagnosis as yet . · Healthcare visit (other): Noneas yetMedDRA releases: 2024-11 · check-in free text available
-
2022-11-03
Report sent to call center — day 35, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-11-03
-
2022-11-10
Survey response — day 42, dose 5MedDRA: Body temperature increased, Skin lesion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Persistent fever 99 to 100+ deg F. Continued wide spread skin lesionsMedDRA releases: 2024-11 · check-in free text available
-
2022-12-28
Survey response — 3 months, dose 5MedDRA: Living in residential institution, Respiratory syncytial virus infection — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: RSV now ok · Healthcare visit (other): Skilled nursing facilityMedDRA releases: 2024-11 · check-in free text available
-
2022-12-28
Report sent to call center — 3 months, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-12-29
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-12-29
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | |
| 2 | 2021-02-03 | Pfizer-BioNTech | |
| 3 | 2021-11-18 | Pfizer-BioNTech | No |
| 4 | 2022-05-09 | Pfizer-BioNTech | No |
| 5 | 2022-09-28 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 successful
Free text
Release 4 — day 21, dose 2
Symptoms: Muscle aches/pain increasing somewhat.
Release 5 — day 28, dose 2
Symptoms: Fatigue increase. Somewhat increased frequency of muscle & bone ache episodes.
Release 8 — 3 months, dose 2
Symptoms: Worsening fatigue, possibly due to preexisting heart condition.
Release 11 — day 14, dose 4
Symptoms: Diahrea
Release 11 — day 21, dose 4
Symptoms: Skin infections worse than past problem. Proceeded to blood - responding to IV antibiotics.
Release 12 — day 35, dose 4
Symptoms: Diarrhea
Release 12 — 3 months, dose 4
Symptoms: Sepsis
Release 12 — day 35, dose 5
Symptoms: Overall torso/arms covered by painful blister-like lesions. No medical diagnosis as yet .
Healthcare visit (other): Noneas yet
Release 12 — day 42, dose 5
Symptoms: Persistent fever 99 to 100+ deg F. Continued wide spread skin lesions
Release 12 — 3 months, dose 5
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Living in residential institution | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Blister | · | · | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Bone pain | ✓ | ✓ | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Haematological infection | · | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Sepsis | · | · | ✓ |
| SD | Skin infection | · | · | ✓ |
| SD | Skin lesion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release